These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33587458)

  • 1. Biological Targets for Dupuytren Disease.
    Lee HH; Satish L
    Ann Plast Surg; 2021 Sep; 87(3):355-358. PubMed ID: 33587458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod: a potential weapon against Dupuytren contracture.
    Namazi H
    Med Hypotheses; 2006; 66(5):991-2. PubMed ID: 16368197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dupuytren disease].
    Wagner P; Román JA; Vergara J
    Rev Med Chil; 2012 Sep; 140(9):1185-90. PubMed ID: 23354642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of platelet-derived growth-factor gene in Dupuytren contracture.
    Terek RM; Jiranek WA; Goldberg MJ; Wolfe HJ; Alman BA
    J Bone Joint Surg Am; 1995 Jan; 77(1):1-9. PubMed ID: 7822340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the management of Dupuytren disease: collagenase.
    Hentz VR; Watt AJ; Desai SS; Curtin C
    Hand Clin; 2012 Nov; 28(4):551-63. PubMed ID: 23101605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
    Nayar SK; Pfisterer D; Ingari JV
    Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease.
    Chisholm J; Gareau AJ; Byun S; Paletz JL; Tang D; Williams J; LeVatte T; Bezuhly M
    Plast Reconstr Surg; 2017 Nov; 140(5):686e-696e. PubMed ID: 29068929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for metformin in the treatment of Dupuytren disease?
    Baeri A; Levraut M; Diazzi S; Camuzard O; Cegarra-Escolano M; Ploumellec MA; Balaguer T; Fassy J; Rezzonico R; Bellusci S; Mari B; Vassaux G
    Biomed Pharmacother; 2022 Jun; 150():112930. PubMed ID: 35427821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt pathway in Dupuytren disease: connecting profibrotic signals.
    van Beuge MM; Ten Dam EJ; Werker PM; Bank RA
    Transl Res; 2015 Dec; 166(6):762-771.e3. PubMed ID: 26470681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
    Fei TT; Chernoff E; Monacco NA; Komatsu DE; Muhlrad S; Sampson SP; Hurst LC; Dagum AB
    J Hand Surg Am; 2019 May; 44(5):417.e1-417.e4. PubMed ID: 30146387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Let's Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target.
    Lambi AG; Morrell NT; Popoff SN; Benhaim P; Barbe MF
    J Hand Surg Glob Online; 2023 Sep; 5(5):682-688. PubMed ID: 37790821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
    Yoon AP; Kane RL; Hutton DW; Chung KC
    JAMA Netw Open; 2020 Oct; 3(10):e2019861. PubMed ID: 33030553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
    Bisson MA; Mudera V; McGrouther DA; Grobbelaar AO
    Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Passive Elongation Through an External Fixator: A Versatile and Beneficial Adjunct Technique to Treat Severe and Recurrent Cases of Dupuytren Contracture.
    Chan PY; Marcus A; Tan V
    Tech Hand Up Extrem Surg; 2023 Jun; 27(2):125-130. PubMed ID: 36534764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
    Badalamente MA; Hurst LC; Benhaim P; Cohen BM
    J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a therapy protocol for increasing correction of severely contracted proximal interphalangeal joints caused by dupuytren disease and treated with collagenase injection.
    Skirven TM; Bachoura A; Jacoby SM; Culp RW; Osterman AL
    J Hand Surg Am; 2013 Apr; 38(4):684-9. PubMed ID: 23474162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers.
    Pess GM; Pess RM; Pess RA
    J Hand Surg Am; 2012 Apr; 37(4):651-6. PubMed ID: 22464232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and Early Recurrence Following Enzymatic (Collagenase) Treatment of Moderate and Severe Dupuytren Contractures.
    David M; Smith G; Pinder R; Craigen M; Waldram M; Mishra A; Dickson D; Wu F; Brewster M
    J Hand Surg Am; 2020 Dec; 45(12):1187.e1-1187.e11. PubMed ID: 32861504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Dupuytren Contracture: Approach to Management.
    Putnam J
    Hand Clin; 2023 Aug; 39(3):455-463. PubMed ID: 37453772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
    Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
    Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.